Filing Details

Accession Number:
0001225208-19-008775
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-04 16:14:54
Reporting Period:
2019-06-01
Accepted Time:
2019-06-04 16:14:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529751 A David Pierce 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp,Pres Medsurg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-01 2,972 $0.00 27,173 No 4 M Direct
Common Stock Disposition 2019-06-01 1,322 $38.41 25,851 No 4 F Direct
Common Stock Acquisiton 2019-06-03 2,640 $7.16 28,491 No 4 M Direct
Common Stock Acquisiton 2019-06-03 2,500 $6.28 30,991 No 4 M Direct
Common Stock Disposition 2019-06-03 5,140 $38.45 25,851 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Stock Units Disposition 2019-06-01 2,972 $0.00 2,972 $0.00
Common Stock Stock Option (Right to Buy) Disposition 2019-06-03 2,500 $0.00 2,500 $6.28
Common Stock Stock Option (Right to Buy) Disposition 2019-06-03 2,640 $0.00 2,640 $7.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,945 2021-06-01 No 4 M Direct
34,997 2022-02-27 No 4 M Direct
0 2021-02-28 No 4 M Direct
Footnotes
  1. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  2. This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
  3. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.21 to $38.67, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017. the first anniversary of the date of grant.
  5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
  6. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 28, 2012, the first anniversary of the grant.